Ross Muken
Stock Analyst
(n/a)
# 4,648
Out of 4,655 analysts
42
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PDCO Patterson Companies | Maintains: In-Line | $23 → $22 | $20.85 | +5.52% | 3 | Oct 8, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $360 → $350 | $220.40 | +58.80% | 7 | Oct 8, 2024 | |
| HSIC Henry Schein | Maintains: In-Line | $70 → $74 | $70.37 | +5.16% | 8 | Oct 8, 2024 | |
| CRL Charles River Laboratories International | Downgrades: In-Line | $225 → $190 | $180.96 | +5.00% | 5 | Oct 7, 2024 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $136.87 | -5.02% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $43.08 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $116.13 | -42.31% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $149.76 | +66.93% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher | Initiates: Outperform | $220 | $557.92 | -60.57% | 1 | Jan 4, 2018 | |
| MBLY Mobileye | Downgrades: In-Line | n/a | $15.57 | - | 1 | Mar 13, 2017 |
Patterson Companies
Oct 8, 2024
Maintains: In-Line
Price Target: $23 → $22
Current: $20.85
Upside: +5.52%
ICON Public Limited Company
Oct 8, 2024
Maintains: Outperform
Price Target: $360 → $350
Current: $220.40
Upside: +58.80%
Henry Schein
Oct 8, 2024
Maintains: In-Line
Price Target: $70 → $74
Current: $70.37
Upside: +5.16%
Charles River Laboratories International
Oct 7, 2024
Downgrades: In-Line
Price Target: $225 → $190
Current: $180.96
Upside: +5.00%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $136.87
Upside: -5.02%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $43.08
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $116.13
Upside: -42.31%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $149.76
Upside: +66.93%
Thermo Fisher
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $557.92
Upside: -60.57%
Mobileye
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $15.57
Upside: -